Skip to main content

Advertisement

Log in

Effect of calcium and vitamin D supplementation on the clinical, hormonal, and metabolic profile in non-obese women with polycystic ovary syndrome

  • Original Article
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

Abstract

Background

In this study, we investigated the effect of calcium and vitamin D (Ca/Vit D) supplementation on the clinical, hormonal, and metabolic profile of patients with low vitamin D levels. In addition, we investigated the effect of Ca/Vit D supplementation on asymmetric dimethylarginine (ADMA) level in patients with polycystic ovary syndrome (PCOS).

Methods

In total, 75 patients aged 19–35 years, with a normal body mass index and a diagnosis of PCOS and Vit D deficiency/insufficiency, were included in the study. Patients received 50,000 IU of vitamin D3 once a week for 8 weeks. Afterward, 2500 mg calcium carbonate equivalent to 1000 mg calcium ion and 9.68 mg cholecalciferol equivalent to 880 IU vitamin D3 were administered orally as a maintenance treatment once a day.

Results

The mean age of the patients was 21.7 ± 3.5. After Ca/Vit D supplementation, Vit D levels significantly increased compared to baseline (8.6 ng/ml) levels. An increase in SHBG levels (p < 0.001), a decrease in total testosterone, FAI (p = 0.042), and ADMA levels (p < 0.001) were observed in the first and third months compared to the onset. Significant improvement compared to baseline was observed in menstrual irregularity and median mFG score.

Conclusion

Ca/Vit D supplementation can improve PCOS symptoms such as menstrual dysfunction, hirsutism, and hyperandrogenism. It may be effective in reducing the risk of cardiovascular disease in patients with PCOS later in life by decreasing ADMA levels, which is an indicator of endothelial dysfunction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Escobar-Morreale HF (2018) Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol 14(5):270–284

    Article  PubMed  Google Scholar 

  2. Parikh G, Varadinova M, Suwandhi P et al (2010) Vitamin D regulates steroidogenesis and insulin-like growth factor Binding Protein-1 (IGFBP-1) Production in Human Ovarian Cells. Horm Metab Res 42(10):754–757

    Article  CAS  PubMed  Google Scholar 

  3. Panidis D, Balaris C, Farmakiotis D et al (2005) Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome. Clin Chem 51(9):1691–1697

    Article  CAS  PubMed  Google Scholar 

  4. Wehr E, Trummer O, Giuliani A et al (2011) Vitamin D associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. Eur J Endocrinol 164(5):741–749

    Article  CAS  PubMed  Google Scholar 

  5. Chan JR, Böger RH, Bode-Böger SM et al (2000) Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans. Arterioscler Thromb Vasc Biol 20(4):1040–1046

    Article  CAS  PubMed  Google Scholar 

  6. Diamanti-Kandarakis E, Alexandraki K, Protogerou A et al (2005) Metformin administration improves endothelial function in women with polycystic ovary syndrome. Eur J Endocrinol 152(5):749–756

    Article  CAS  PubMed  Google Scholar 

  7. Choi YS, Yang HI, Cho S et al (2012) Serum asymmetric dimethylarginine, apelin, and tumor necrosis factor-α levels in non-obese women with polycystic ovary syndrome. Steroids 77(13):1352–1358

    Article  CAS  PubMed  Google Scholar 

  8. Shojaeian Z, Sadeghi R, Latifnejad RR (2019) Calcium and vitamin D supplementation effects on metabolic factors, menstrual cycles and follicular responses in women with polycystic ocvary syndrome: a systematic review and meta-analysis. Caspian J Intern Med 10(4):359–369

    PubMed  PubMed Central  Google Scholar 

  9. Pergialiotis V, Karampetsou N, Panagopoulos P et al (2017) The effect of vitamin D supplementation on hormonal and glycaemic profile of patients with PCOS: a meta-analysis of randomised trials. Int J Clin Pract 71(6):1–8

    Article  Google Scholar 

  10. Wehr E, Pieber TR, Obermayer-Pietsch B (2011) Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in PCOS women-a pilot study. J Endocrinol Invest 34(10):757–763

    CAS  PubMed  Google Scholar 

  11. Holick MF, Binkley NC, Bischoff-Ferrari HA et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930

    Article  CAS  PubMed  Google Scholar 

  12. Joham AE, Teede HJ, Cassar S et al (2016) Vitamin D in polycystic ovary syndrome: relationship to obesity and insulin resistance. Mol Nutr Food Res 60(1):110–118

    Article  CAS  PubMed  Google Scholar 

  13. Rashidi H, Toolabi M, Najafian M et al (2016) The relationship of serum 25-dihydroxy vitamin D3 concentrations with metabolic parameters in non-obese women with polycystic ovarian syndrome. Middle East Fertil Soc J 21(4):264–268

    Article  Google Scholar 

  14. Bonakdaran S, Mazloom Khorasani Z, Davachi B et al (2012) The effects of calcitriol on improvement of insulin resistance, ovulation and comparison with metformin therapy in PCOS patients: a randomized placebo- controlled clinical trial. Iran J Reprod Med 10(5):465–472

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Colonese F, Laganà AS, Colonese E et al (2015) The pleiotropic effects of vitamin D in gynaecological and obstetric diseases: an overview on a hot topic. Biomed Res Int 2015:986281

    Article  PubMed  PubMed Central  Google Scholar 

  16. Dabrowski FA, Grzechocinska B, Wielgos M (2015) The role of vitamin D in reproductive health–a trojan horse or the golden fleece?. Nutrients 7(6):4139–4153

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Ranjzad F, Mahban A, Shemirani AI et al (2011) Influence of gene variants related to calcium homeostasis on biochemical parameters of women with polycystic ovary syndrome. J Assist Reprod Genet 28(3):225–232

    Article  PubMed  Google Scholar 

  18. Gupta T, Rawat M, Gupta N et al (2017) Study of effect of vitamin D supplementation on the clinical, hormonal and metabolic profile of the PCOS women. J Obstet Gynecol India 67(5):349–355

    Article  CAS  Google Scholar 

  19. Tehrani HG, Mostajeran F, Shahsavari S (2014) The effect of calcium and vitamin D supplementation on menstrual cycle, body mass index and hyperandrogenism state of women with poly cystic ovarian syndrome. J Res Med Sci 19(9):875–880

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Pal L, Berry A, Coraluzzi L et al (2012) Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome. Gynecol Endocrinol 28:965–968

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Firouzabadi RD, Aflatoonian A, Modarresi S et al (2012) Therapeutic effects of calcium & vitamin D supplementation in women with PCOS. Complement Ther Clin Pract 18(2):85–88

    Article  PubMed  Google Scholar 

  22. Ostadmohammadi V, Jamilian M, Bahmani F et al (2019) Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome. J Ovarian Res 12(1):5

    Article  PubMed  PubMed Central  Google Scholar 

  23. DeUgarte CM, Bartolucci AA, Azziz R (2005) Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 83:1454

    Article  CAS  PubMed  Google Scholar 

  24. Asemi Z, Foroozanfard F, Hashemi T et al (2015) Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Clin Nutr 34(4):586–592

    Article  CAS  PubMed  Google Scholar 

  25. Xue Y, Xu P, Xue K et al (2017) Effect of vitamin D on biochemical parameters in polycystic ovary syndrome women: a meta-analysis. Arch Gynecol Obstet 295(2):487–496

    Article  CAS  PubMed  Google Scholar 

  26. Charitidou C, Farmakiotis D, Zournatzi V et al (2008) The administration of estrogens, combined with antiandrogens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome. Atherosclerosis 196(2):958–965

    Article  CAS  PubMed  Google Scholar 

  27. Heutling D, Schulz H, Nickel I et al (2008) Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment. J Clin Endocrinol Metab 93(1):82–90

    Article  CAS  PubMed  Google Scholar 

  28. Demirel F, Bideci A, Cinaz P et al (2007) Serum leptin, oxidized low-density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidemia in adolescent girls with polycystic ovary syndrome. Clin Endocrinol (Oxf) 67(1):129–134

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank all the participants in this study.

Author information

Authors and Affiliations

Authors

Contributions

ZSS: protocol/project development, data collection and management, data analysis, and manuscript writing. YSA: data collection and management, data analysis and manuscript writing. SÖ: data collection and management. ÜA: data collection and management. AS, ÇÇ: protocol/project development, data analysis, and manuscript writing.

Corresponding author

Correspondence to Zekiye Soykan Sert.

Ethics declarations

Ethics approval

This study protocol was approved by the Clinical Research Ethical Committee of Selçuk University Faculty of Medicine with a protocol number of 2015/6 and conducted in accordance with the Declaration of Helsinki and Good Clinical Practices.

Consent to participate

Not applicable.

Consent for publication

All authors have read and approved the final version of this manuscript and have consented for publication.

Conflicts of interest

No conflict of interest was declared by the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sert, Z.S., Yılmaz, S.A., Seçilmiş, Ö. et al. Effect of calcium and vitamin D supplementation on the clinical, hormonal, and metabolic profile in non-obese women with polycystic ovary syndrome. Ir J Med Sci 191, 2657–2662 (2022). https://doi.org/10.1007/s11845-021-02899-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-021-02899-3

Keywords

Navigation